GenSight Biologics S.A.

ENXTPA:SIGHT Stok Raporu

Piyasa değeri: €40.4m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

GenSight Biologics Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 0/6

GenSight Biologics has a total shareholder equity of €-24.8M and total debt of €21.2M, which brings its debt-to-equity ratio to -85.5%. Its total assets and total liabilities are €15.0M and €39.8M respectively.

Anahtar bilgiler

-85.5%

Borç/özkaynak oranı

€21.24m

Borç

Faiz karşılama oranın/a
Nakit€6.94m
Eşitlik-€24.83m
Toplam yükümlülükler€39.82m
Toplam varlıklar€14.99m

Son finansal sağlık güncellemeleri

Recent updates

Is There An Opportunity With GenSight Biologics S.A.'s (EPA:SIGHT) 30% Undervaluation?

Dec 22
Is There An Opportunity With GenSight Biologics S.A.'s (EPA:SIGHT) 30% Undervaluation?

Is GenSight Biologics S.A. (EPA:SIGHT) Trading At A 39% Discount?

Sep 20
Is GenSight Biologics S.A. (EPA:SIGHT) Trading At A 39% Discount?

Health Check: How Prudently Does GenSight Biologics (EPA:SIGHT) Use Debt?

Aug 17
Health Check: How Prudently Does GenSight Biologics (EPA:SIGHT) Use Debt?

Rock star Growth Puts GenSight Biologics (EPA:SIGHT) In A Position To Use Debt

Aug 04
Rock star Growth Puts GenSight Biologics (EPA:SIGHT) In A Position To Use Debt

GenSight Biologics S.A. (EPA:SIGHT) Shares Could Be 27% Below Their Intrinsic Value Estimate

Jun 14
GenSight Biologics S.A. (EPA:SIGHT) Shares Could Be 27% Below Their Intrinsic Value Estimate

GenSight Biologics S.A. (EPA:SIGHT): Is Breakeven Near?

May 10
GenSight Biologics S.A. (EPA:SIGHT): Is Breakeven Near?

Analysts Expect Breakeven For GenSight Biologics S.A. (EPA:SIGHT) Before Long

Feb 02
Analysts Expect Breakeven For GenSight Biologics S.A. (EPA:SIGHT) Before Long

A Quick Analysis On GenSight Biologics' (EPA:SIGHT) CEO Salary

Dec 09
A Quick Analysis On GenSight Biologics' (EPA:SIGHT) CEO Salary

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: SIGHT has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Uzun Vadeli Yükümlülükler: SIGHT has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: SIGHT has negative shareholder equity, which is a more serious situation than a high debt level.

Borcun Azaltılması: SIGHT's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Bilanço


Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: SIGHT has less than a year of cash runway based on its current free cash flow.

Tahmini Nakit Akışı: SIGHT has less than a year of cash runway if free cash flow continues to grow at historical rates of 0.9% each year.


Sağlıklı şirketleri keşfedin